These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3433107

  • 1. Cytological screening for precancerous lesions of the cervix.
    Sng I.
    Singapore Med J; 1987 Oct; 28(5):415-21. PubMed ID: 3433107
    [No Abstract] [Full Text] [Related]

  • 2. Significance of physical findings in diagnosis of cervical carcinoma.
    Moller KA, Fogh H, Moller PE, Strandbygard K.
    Dan Med Bull; 1972 Jun; 19(4):122-7. PubMed ID: 5041568
    [No Abstract] [Full Text] [Related]

  • 3. [Significance of systematic examinations of working women in the detection of uterine cervix cancer].
    Mekuli S, Krajinović S, Udicki S, Bosković M, Nastasović M, Ducić S, Maric R, Obradović M, Sokić S, Radovanović Z.
    Srp Arh Celok Lek; 1969 Jun; 97(6):631-9. PubMed ID: 5198723
    [No Abstract] [Full Text] [Related]

  • 4. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G, Cariaggi P, Ottaviano M, Marchionni M, Mincione G, Bartoloni St Omer F.
    Minerva Ginecol; 1975 May; 27(5):418-21. PubMed ID: 1134695
    [No Abstract] [Full Text] [Related]

  • 5. [Program of opportune diagnosis of the cervix uteri cancer in the I.M.S.S].
    Gallegos Vargas G, Guillen Abasolo D.
    Prensa Med Mex; 1970 May; 35(3):93-8. PubMed ID: 5518726
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F, Duhamel A, Trinh QD, Deken V, Leroy JL, Beuscart R.
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of preclinical lesions of the cervix uteri].
    Dabancens A.
    Rev Med Chil; 1986 Jun; 114(6):586-90. PubMed ID: 3575955
    [No Abstract] [Full Text] [Related]

  • 8. The natural history of Pap test screening in a rural population.
    Rosenfeld JA.
    Tenn Med; 1998 May; 91(5):179-82. PubMed ID: 9584605
    [No Abstract] [Full Text] [Related]

  • 9. [Epidemiological aspects of detection of carcinoma of the cervix in the region of Ljubljana].
    Kovacic J, Bonta S.
    Minerva Ginecol; 1971 Jan 15; 23(1):14-6. PubMed ID: 5553174
    [No Abstract] [Full Text] [Related]

  • 10. [Screening for precancerous conditions and preclinical carcinoma of the uterine cervix in the Western Bohemian Region].
    Bouda J, Mleziva J, Filaun J, Plánicková E.
    Cesk Gynekol; 1990 Sep 15; 55(8):629-34. PubMed ID: 2225130
    [No Abstract] [Full Text] [Related]

  • 11. [Results of the study of the cervix in patients under contraceptive therapy].
    García-Huidobro M, Puga J.
    Rev Chil Obstet Ginecol; 1972 Sep 15; 37(1):1-5. PubMed ID: 4669129
    [No Abstract] [Full Text] [Related]

  • 12. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S, Nieminen U, Kauraniemi T.
    Ann Chir Gynaecol Fenn; 1974 Sep 15; 63(2):104-12. PubMed ID: 4853102
    [No Abstract] [Full Text] [Related]

  • 13. Cytological mass screening in Ostfold County, Norway.
    Magnus K, Langmark F.
    IARC Sci Publ; 1986 Sep 15; (76):87-90. PubMed ID: 3570418
    [No Abstract] [Full Text] [Related]

  • 14. [A mass survey of the incidence of cervix cancer].
    Thorarinsson A, Jensson O, Bjarnason O.
    Nord Med; 1967 Dec 07; 78(49):1608-11. PubMed ID: 6073716
    [No Abstract] [Full Text] [Related]

  • 15. False negative rate in mass screening for cervical cancer.
    Sato S, Mikino H, Matsunaga G, Yajima A.
    Acta Cytol; 1998 Dec 07; 42(3):836-7. PubMed ID: 9622728
    [No Abstract] [Full Text] [Related]

  • 16. Invasive versus preinvasive cervical carcinoma: 1961-1965.
    Knudtzen S, Hill JH.
    Mo Med; 1968 Aug 07; 65(8):669-70. PubMed ID: 5664967
    [No Abstract] [Full Text] [Related]

  • 17. Dysplasia, carcinoma in situ, and invasive carcinoma of the cervix uteri in previously screened women.
    Hoeg K, Roger V.
    Scand J Clin Lab Invest Suppl; 1968 Aug 07; 106():173-80. PubMed ID: 5731703
    [No Abstract] [Full Text] [Related]

  • 18. Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.
    Messelt OT, Höeg K.
    Acta Cytol; 1967 Aug 07; 11(1):39-40. PubMed ID: 5230439
    [No Abstract] [Full Text] [Related]

  • 19. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P, Kallio M, Hakama M.
    Obstet Gynecol; 1995 Jun 07; 85(6):1017-21. PubMed ID: 7770247
    [Abstract] [Full Text] [Related]

  • 20. [The incidence of borderline and pathologic findings in young females within the scope of gynecologic-cytologic screening studies].
    Neumann HG, Barten G, Barten M, Schröder M.
    Zentralbl Gynakol; 1989 Jun 07; 111(14):947-51. PubMed ID: 2800778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.